Bergisch Gladbach, Germany

Thomas Lehmann


Average Co-Inventor Count = 10.2

ph-index = 1


Location History:

  • Bergisch Gladbach, DE (2004 - 2006)
  • Wulfrath, DE (2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Lehmann: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Lehmann is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating inflammatory diseases. With a total of 3 patents to his name, Lehmann's work has had a meaningful impact on medical research and drug development.

Latest Patents

Lehmann's latest patents include innovative compounds that serve as integrin receptor antagonists. The first patent focuses on beta-amino acid derivatives, detailing the compounds' general formula, processes for their preparation, and their pharmaceutical applications. The second patent involves succinic acid derivatives, which also outlines the compounds' general formula and their use in pharmaceutical compositions aimed at treating inflammatory diseases. These inventions highlight Lehmann's commitment to advancing therapeutic options in medicine.

Career Highlights

Throughout his career, Thomas Lehmann has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug development.

Collaborations

Lehmann has had the opportunity to work alongside esteemed colleagues such as Markus Albers and Gerhard Hessler. These collaborations have further enriched his research and innovation in the field of pharmaceutical chemistry.

Conclusion

In summary, Thomas Lehmann is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents aimed at treating inflammatory diseases. His contributions continue to influence the development of new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…